IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,746,621 | -47.5% | 236,082 | -37.6% | 0.01% | -44.4% |
| Q2 2023 | $7,142,125 | +245.9% | 378,491 | -29.6% | 0.01% | +200.0% |
| Q1 2023 | $2,064,776 | +14.5% | 537,702 | +47.9% | 0.00% | 0.0% |
| Q4 2022 | $1,803,277 | -99.9% | 363,564 | +5.6% | 0.00% | 0.0% |
| Q3 2022 | $1,645,467,000 | +485.8% | 344,240 | +451.5% | 0.00% | – |
| Q2 2022 | $280,908,000 | +87.7% | 62,424 | +98.5% | 0.00% | – |
| Q1 2022 | $149,669,000 | -67.2% | 31,443 | -48.9% | 0.00% | -100.0% |
| Q4 2021 | $456,783,000 | +36.2% | 61,561 | +4.1% | 0.00% | – |
| Q3 2021 | $335,409,000 | +94.6% | 59,155 | +126.2% | 0.00% | – |
| Q2 2021 | $172,328,000 | -72.9% | 26,150 | -66.6% | 0.00% | -100.0% |
| Q1 2021 | $635,008,000 | +335.8% | 78,396 | +247.0% | 0.00% | – |
| Q4 2020 | $145,718,000 | +0.1% | 22,592 | -44.1% | 0.00% | – |
| Q3 2020 | $145,624,000 | +55.2% | 40,451 | +98.3% | 0.00% | – |
| Q2 2020 | $93,822,000 | -65.4% | 20,396 | -74.3% | 0.00% | -100.0% |
| Q1 2020 | $270,829,000 | +131.7% | 79,422 | +246.9% | 0.00% | – |
| Q4 2019 | $116,874,000 | +110.7% | 22,894 | -0.1% | 0.00% | – |
| Q3 2019 | $55,464,000 | +61.2% | 22,919 | +44.6% | 0.00% | – |
| Q2 2019 | $34,405,000 | -57.5% | 15,855 | -46.9% | 0.00% | – |
| Q1 2019 | $80,942,000 | +44373.6% | 29,868 | +78500.0% | 0.00% | – |
| Q4 2018 | $182,000 | -99.5% | 38 | -99.1% | 0.00% | – |
| Q3 2018 | $39,992,000 | -2.7% | 4,223 | 0.0% | 0.00% | – |
| Q2 2018 | $41,090,000 | -81.0% | 4,223 | -79.5% | 0.00% | – |
| Q1 2018 | $216,775,000 | +64.9% | 20,606 | +0.5% | 0.00% | – |
| Q4 2017 | $131,443,000 | +90.3% | 20,506 | +127.1% | 0.00% | – |
| Q3 2017 | $69,087,000 | +0.8% | 9,031 | -6.3% | 0.00% | – |
| Q2 2017 | $68,540,000 | +2489.3% | 9,640 | +1309.4% | 0.00% | – |
| Q1 2017 | $2,647,000 | -74.1% | 684 | -86.4% | 0.00% | – |
| Q4 2016 | $10,227,000 | -44.6% | 5,013 | -27.2% | 0.00% | – |
| Q3 2016 | $18,463,000 | +82.5% | 6,889 | +109.8% | 0.00% | – |
| Q2 2016 | $10,115,000 | +36.0% | 3,284 | +276.2% | 0.00% | – |
| Q1 2016 | $7,438,000 | -97.5% | 873 | -96.1% | 0.00% | -100.0% |
| Q4 2015 | $301,091,000 | +59.2% | 22,188 | +12.6% | 0.00% | – |
| Q3 2015 | $189,091,000 | +44.4% | 19,697 | +116.2% | 0.00% | – |
| Q2 2015 | $130,988,000 | +266.4% | 9,109 | +128.1% | 0.00% | – |
| Q1 2015 | $35,746,000 | +202.2% | 3,994 | +106.0% | 0.00% | – |
| Q4 2014 | $11,828,000 | -79.8% | 1,939 | -64.9% | 0.00% | – |
| Q3 2014 | $58,436,000 | +4881.8% | 5,518 | +5473.7% | 0.00% | – |
| Q2 2014 | $1,173,000 | +120.9% | 99 | +141.5% | 0.00% | – |
| Q1 2014 | $531,000 | -96.7% | 41 | -96.3% | 0.00% | – |
| Q4 2013 | $16,093,000 | -95.9% | 1,097 | -95.3% | 0.00% | – |
| Q3 2013 | $396,498,000 | -19.0% | 23,296 | -21.0% | 0.00% | – |
| Q2 2013 | $489,239,000 | – | 29,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |